In addition, in accordance with point 4(b) of Annex VII to Regulation (EU) 2024/573, a reference value is to be calculated for each producer and importer that has reported on the placing on the Union market of hydrofluorocarbons for being used for the production of metered dose inhalers for the delivery of pharmaceutical ingredients. That reference value is to be calculated on the basis of the annual average of the quantities of hydrofluorocarbons lawfully placed on the Union market for such usage, from 1 January 2020 as reported under Article 19 of Regulation (EU) No 517/2014 and under Article 26 of Regulation (EU) 2024/573, for the years available, on the basis of available data. Accordingly, for calculating the reference values referred to in point 4(b) of Annex VII to Regulation (EU) 2024/573 for the period from 1 January 2027 to 31 December 2029, any data reported by producers and importers in accordance with Article 19 of Regulation (EU) No 517/2014 for 2020, 2021, 2022 and 2023 or in accordance with Article 26 of Regulation (EU) 2024/573 for 2024 should be taken into account.
Recital 4, Decision_act (EU) 2026/1382
In forcesince 22 Jun 2026
- celex=32014R0517